High-dose intravenous glucocorticoid therapy for Graves' ophthalmopathy: where are we now?

Thyroid. 2012 Jan;22(1):1-2. doi: 10.1089/thy.2012.2201.ed.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Female
  • Graves Ophthalmopathy / drug therapy*
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Liver / physiopathology*
  • Male
  • Methylprednisolone / adverse effects*

Substances

  • Immunosuppressive Agents
  • Methylprednisolone